MedTrace Logo

External Versus Internal Feedback in Patients With Chronic Ankle Instability

NCT04131842 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2024-08-19

No results posted yet for this study

Summary

Although altered biomechanics has been well documented as an impairment associated with chronic ankle instability (CAI), effective interventions targeting biomechanics with long-term outcomes measuring patient-reported outcomes (PROs) are absent. Evidence suggests that external focus of attention (ExFOCUS), internal focus of attention (InFOCUS) feedback, and auditory feedback during movement training can alter biomechanics in other patient populations, with ExFOCUS and auditory enhancing retention of learned biomechanics. Therefore, this randomized controlled trial will determine if a 4-week (12 session) impairment-based rehabilitation program that includes feedback (ExFOCUS or InFOCUS or Auditory) can (1) decrease ankle inversion kinematics and lateral plantar pressure during walking and (2) improve self-reported function.

Conditions

  • Ankle Injuries
  • Ankle Inversion Sprain

Interventions

OTHER

External focus of attention visual feedback

Patients will receive external focus of attention visual feedback during the impairment-based rehabilitation program.

OTHER

External focus of attention auditory feedback

Patients will receive external focus of attention auditory feedback during the impairment-based rehabilitation program.

OTHER

Internal focus of attention video feedback

Patients will receive internal focus of attention visual feedback during the impairment-based rehabilitation program.

OTHER

No feedback

Patients will receive no feedback during the impairment-based rehabilitation program.

Sponsors & Collaborators

  • University of North Carolina, Charlotte

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-18
Primary Completion
2024-07-01
Completion
2024-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04131842 on ClinicalTrials.gov